ESC 365 - What's the next step in HFpEF?

Open Access

What's the next step in HFpEF?

Session: The obesity phenotype of HFpEF: new therapies on our door step?

Topic: Chronic Heart Failure

Speaker: Doctor M. Kosiborod (Kansas City, US)

Sponsored by Novo Nordisk

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

55 presentations

10 followers

4 more presentations in this session

Opening & welcome

Speaker: Doctor M. Kosiborod (Kansas City, US)

HFpEF: what is the status quo?

Speaker: Professor C. Lam (Singapore, SG)

Obesity: a root cause of HFpEF

Speaker: Professor M. Cikes (Zagreb, HR)

Panel discussion and Q&A

Access the full session

The obesity phenotype of HFpEF: new therapies on our door step?

Speakers: Doctor M. Kosiborod, Doctor M. Kosiborod, Professor C. Lam, Professor M. Cikes

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources